ARTICLE | Clinical News
Envarsus tacrolimus regulatory update
August 4, 2014 7:00 AM UTC
The European Commission approved an MAA for Envarsus tacrolimus from Veloxis to prevent organ rejection in adult kidney and liver transplant patients. Veloxis said partner Chiesi Farmaceutici S.p.A. ...